Showing results (2381-2390 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|April 10, 2023
Associations Between Psycho-Social-Spiritual Interventions, Fewer Aggressive End-of-Life Measures, and Increased Time After Final Oncologic TreatmentMichael Schultz, Svetlana Baziliansky, Inbal Mitnik, et al.The Oncologist|April 20, 2023
Patient Understanding of Oncology Clinical Trial Endpoints in Direct-to-Consumer Television AdvertisingHelen W Sullivan, Amie C O'Donoghue, Vanessa Boudewyns, et al.The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.The Oncologist|April 18, 2023
A Belgian Population-Based Study Reveals Subgroups of Right-sided Colorectal Cancer with a Better Prognosis Compared to Left-sided CancerKatleen Janssens, Erik Fransen, Guy Van Camp, et al.The Oncologist|April 3, 2023
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint InhibitorsIgor Stukalin, Vishal Navani, Mehul Gupta, et al.The Oncologist|April 21, 2023
Risk Factors for Immune Checkpoint Inhibitor Immunotherapy Toxicity Among Older Adults with CancerAndrew C Johns, Mike Yang, Lai Wei, et al.The Oncologist|March 30, 2023
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study ResultsKim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, et al.The Oncologist|April 4, 2023
Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International StudyPedro C Barata, Andrea Leith, Amanda Ribbands, et al.The Oncologist|April 4, 2023
Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International StudyPedro C Barata, Andrea Leith, Amanda Ribbands, et al.The Oncologist|March 30, 2021
Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare AnalysisMelissa A L Vyfhuis, Ikumi Suzuki, Soren M Bentzen, et al.Pageof 571